Gene: DLEC1
Official Full Name: DLEC1 cilia and flagella associated proteinprovided by HGNC
Gene Summary: The cytogenetic location of this gene is 3p21.3, and it is located in a region that is commonly deleted in a variety of malignancies. Down-regulation of this gene has been observed in several human cancers including lung, esophageal, renal tumors, and head and neck squamous cell carcinoma. In some cases, reduced expression of this gene in tumor cells is a result of aberrant promoter methylation. Several alternatively spliced transcripts have been observed that contain disrupted coding regions and likely encode nonfunctional proteins.[provided by RefSeq, Mar 2016]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA11861 | DLEC1 Knockout cell line (AC16) | Human | DLEC1 | 1:3-1:4 | negative | Online Inquiry |
| KOA27309 | DLEC1 Knockout cell line (BEAS-2B) | Human | DLEC1 | 1:3~1:4 | negative | Online Inquiry |
| KOA42745 | DLEC1 Knockout cell line (U-2932) | Human | DLEC1 | 1:2-1:4 | negative | Online Inquiry |
| KOA58123 | DLEC1 Knockout cell line (TPC-1) | Human | DLEC1 | 1:5-1:8 | negative | Online Inquiry |
| KOA73548 | DLEC1 Knockout cell line (NCM460) | Human | DLEC1 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.